You just read:

Trovagene Announces Research Collaboration with Nektar Therapeutics to Evaluate Efficacy of the Combination of Onvansertib and ONZEALD™ in Models of Colorectal Cancer

News provided by

Trovagene, Inc.

May 23, 2019, 08:00 ET